Vimarsana
Biggest News Aggregation in the World

Dopamine Antagonists News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dopamine Antagonists. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dopamine Antagonists Today - Breaking & Trending Today

Insights Into The Global Antiemetics And Antinauseants Market 2022-2031 Forecast Period - Vimarsana News

Insights Into The Global Antiemetics And Antinauseants Market 2022-2031 Forecast Period

The Business Research Company’s Antiemetics And Antinauseants Global Market Report 2022: Market Size, Trends, And Forecast To 2026

Zydus Cadila receives USFDA approval for Fluphenazine Hydrochloride Tablets - Vimarsana News

Zydus Cadila receives USFDA approval for Fluphenazine Hydrochloride Tablets

Read more about Zydus Cadila receives USFDA approval for Fluphenazine Hydrochloride Tablets on Business Standard. Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic. The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad. The group now has 318 approvals

Unichem Laboratories receives USFDA approval for Amitriptyline HCl Tablets - Vimarsana News

Unichem Laboratories receives USFDA approval for Amitriptyline HCl Tablets

Unichem Laboratories is pleased to announce that it has received ANDA approval for its Amitriptyline HCl Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ELAVIL (Amitriptyline Hydrochloride) 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of AstraZeneca Pharmaceuticals LP. Amitriptyline HCl Tablets are indicated for the relief of symptoms of depression. The product will be commercialized from Unichem's Goa Plant. Powered by Capital Market - Live News (This story has not been edited by Business...